Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

199 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preoperative chemotherapy and radiotherapy concomitant to cetuximab in resectable stage IIIB NSCLC: a multicentre phase 2 trial (SAKK 16/08).
Curioni-Fontecedro A, Perentes JY, Gelpke H, Xyrafas A, Bouchaab H, Mach N, Matzinger O, Stojcheva N, Frueh M, Weder W, Cathomas R, Gargiulo P, Bubendorf L, Pless M, Betticher D, Peters S; Swiss Group of Clinical Cancer Research (SAKK). Curioni-Fontecedro A, et al. Among authors: pless m. Br J Cancer. 2019 May;120(10):968-974. doi: 10.1038/s41416-019-0447-0. Epub 2019 Apr 16. Br J Cancer. 2019. PMID: 30988393 Free PMC article. Clinical Trial.
Peptide Receptor Radionuclide Therapy for a Phosphaturic Mesenchymal Tumor.
Häfliger S, Seidel AK, Schoch E, Reichmann J, Wild D, Steinmann-Schwager S, Pless M. Häfliger S, et al. Among authors: pless m. Case Rep Oncol. 2020 Nov 30;13(3):1373-1380. doi: 10.1159/000510334. eCollection 2020 Sep-Dec. Case Rep Oncol. 2020. PMID: 33442358 Free PMC article.
Extended resection for potentially operable patients with stage III non-small cell lung cancer after induction treatment.
Furrer K, Weder W, Eboulet EI, Betticher D, Pless M, Stupp R, Krueger T, Perentes JY, Schmid RA, Lardinois D, Furrer M, Früh M, Peters S, Curioni-Fontecedro A, Stahel RA, Rothschild SI, Hayoz S, Opitz I. Furrer K, et al. Among authors: pless m. J Thorac Cardiovasc Surg. 2022 Dec;164(6):1587-1602.e5. doi: 10.1016/j.jtcvs.2022.03.034. Epub 2022 Apr 18. J Thorac Cardiovasc Surg. 2022. PMID: 35688713
Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08).
Früh M, Cathomas R, Siano M, Tscherry G, Zippelius A, Mamot C, Erdmann A, Krasniqi F, Rauch D, Simcock M, Küttel E, Fustier P, Pless M; Swiss Group for Clinical Cancer Research. Früh M, et al. Among authors: pless m. Clin Lung Cancer. 2013 Jan;14(1):34-9. doi: 10.1016/j.cllc.2012.04.001. Epub 2012 May 24. Clin Lung Cancer. 2013. PMID: 22633220 Clinical Trial.
EGFR exon-level biomarkers of the response to bevacizumab/erlotinib in non-small cell lung cancer.
Baty F, Rothschild S, Früh M, Betticher D, Dröge C, Cathomas R, Rauch D, Gautschi O, Bubendorf L, Crowe S, Zappa F, Pless M, Brutsche M; Swiss Group for Clinical Cancer Research. Baty F, et al. Among authors: pless m. PLoS One. 2013 Sep 10;8(9):e72966. doi: 10.1371/journal.pone.0072966. eCollection 2013. PLoS One. 2013. PMID: 24039832 Free PMC article.
199 results